Latest News about RCUS
Recent news which mentions RCUS
From Benzinga
From Benzinga
From InvestorPlace
3 Analyst Upgrades That Smart Investors Won’t Ignore
May 17, 2023
From InvestorPlace
Earnings Scheduled For February 28, 2023
February 28, 2023
From Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
From InvestorPlace
Dow Jumps 150 Points; Crude Oil Rises 1%
December 20, 2022
From Benzinga
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 20, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 20, 2022
From Benzinga
Nasdaq Edges Lower; Gold Rises 1.5%
December 20, 2022
From Benzinga
Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday
December 20, 2022
From Benzinga
US Stocks Edge Higher; Dow Rises 50 Points
December 20, 2022
From Benzinga
Gilead-Arcus Partnered Domvanalimab Combo Study Show Improved Progression-Free Survival In Lung Cancer Patients
December 20, 2022
From Benzinga
Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures
November 28, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
From Benzinga
ON Semiconductor, Global Payments And Other Big Losers From Monday
November 01, 2022
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
From Benzinga
Citi reduces Arcus Biosciences (RCUS) PT to $40. RCUS is currently trading at $25.45.
August 18, 2022
Tickers
RCUS
From Best Stocks
From Benzinga
99 Biggest Movers From Yesterday
May 12, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.